Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Altman Z2-Score: -7.03 (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02252 Shanghai MicroPort MedBot (Group) Co Ltd HKSE:02252
45 GF Score
Price HK$25.48
GF Value HK$81.81
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Shanghai MicroPort MedBot (Group) Co Altman Z2-Score?

Shanghai MicroPort MedBot (Group) Co HKSE:02252 -1.32% 45 Altman Z2-Score is -7.03 as of Aug. 14, 2026. GuruFocus rates HKSE:02252 with a GF Score™ of 45/100 and a GF Value™ of HK$81.81 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 840 Medical Devices & Instruments companies, Shanghai MicroPort MedBot (Group) Co ranks worse than 80.24% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Warning Sign:

Shanghai MicroPort MedBot (Group) Co has a Altman Z2-Score of -7.03, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Shanghai MicroPort MedBot (Group) Co's Altman Z2-Score or its related term are showing as below:

HKSE:02252' s Altman Z2-Score Range Over the Past 10 Years
Min: -10.19   Med: -4.15   Max: 10.08
Current: -7.03

During the past 7 years, Shanghai MicroPort MedBot (Group) Co's highest Altman Z2-Score was 10.08. The lowest was -10.19. And the median was -4.15.


Shanghai MicroPort MedBot (Group) Co  (HKSE:02252) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Shanghai MicroPort MedBot (Group) Co Altman Z2-Score Related Terms


Shanghai MicroPort MedBot (Group) Co Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Shanghai MicroPort MedBot (Group) Co's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai MicroPort MedBot (Group) Co Altman Z2-Score Chart

Shanghai MicroPort MedBot (Group) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z2-Score
Get a 7-Day Free Trial 9.23 1.53 -10.19 -10.14 -7.03

Shanghai MicroPort MedBot (Group) Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.19 0.00 -10.14 0.00 -7.03

HKSE:02252 vs ABT, SYK, MDT: Altman Z2-Score Comparison

For the Medical Devices subindustry, Shanghai MicroPort MedBot (Group) Co's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai MicroPort MedBot (Group) Co Altman Z2-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai MicroPort MedBot (Group) Co's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Shanghai MicroPort MedBot (Group) Co's Altman Z2-Score falls into.


HKSE:02252
45GF Score
Shanghai MicroPort MedBot (Group) Co Ltd HKSE:02252
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai MicroPort MedBot (Group) Co Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Shanghai MicroPort MedBot (Group) Co's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.4386+3.26*-2.8189+6.72*-0.1757+1.05*0.4394
=-7.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was HK$1,474.4 Mil.
Total Current Assets was HK$1,144.1 Mil.
Total Current Liabilities was HK$497.3 Mil.
Retained Earnings was HK$-4,156.0 Mil.
Pre-Tax Income was HK$-280.7 Mil.
Interest Expense was HK$-21.7 Mil.
Total Liabilities was HK$1,032.6 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(1144.052 - 497.335)/1474.358
=0.4386

X2=Retained Earnings/Total Assets
=-4156.015/1474.358
=-2.8189

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-280.727 - -21.729)/1474.358
=-0.1757

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(453.682 - 0)/1032.551
=0.4394

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Shanghai MicroPort MedBot (Group) Co has a Altman Z2-Score of -7.03 indicating it is in Distress Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of -7.03 mean?
Shanghai MicroPort MedBot (Group) Co (HKSE:02252) has a Altman Z2-Score of -7.03 as of Aug. 14, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Shanghai MicroPort MedBot (Group) Co and its competitors. According to the industry distribution chart, Shanghai MicroPort MedBot (Group) Co ranks #674 out of 840 companies in the Medical Devices & Instruments industry, placing it in the top 80.2%.
Is Shanghai MicroPort MedBot (Group) Co's Altman Z2-Score too high?
Shanghai MicroPort MedBot (Group) Co's current Altman Z2-Score is -7.03. Based on the distribution chart, Shanghai MicroPort MedBot (Group) Co ranks #674 out of 840 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shanghai MicroPort MedBot (Group) Co has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai MicroPort MedBot (Group) Co's Altman Z2-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai MicroPort MedBot (Group) Co ranks #674 out of 840 companies for Altman Z2-Score. This places Shanghai MicroPort MedBot (Group) Co in the lower half of its industry. The industry median Altman Z2-Score is 3.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Medical Devices & Instruments company?
The median Altman Z2-Score among Medical Devices & Instruments companies is 3.45, based on 840 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Shanghai MicroPort MedBot (Group) Co and its competitors. For the Medical Devices & Instruments industry, the median Altman Z2-Score is 3.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai MicroPort MedBot (Group) Co's current Altman Z2-Score is -7.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai MicroPort MedBot (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai MicroPort MedBot (Group) Co (HKSE:02252) is currently considered Possible Value Trap. The stock's GF Value™ is HK$81.81, compared to a current price of HK$25.48 — trading 68.9% below its estimated fair value. The current Altman Z2-Score is -7.03. Shanghai MicroPort MedBot (Group) Co's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Shanghai MicroPort MedBot (Group) Co (HKSE:02252), the current Altman Z2-Score is -7.03 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai MicroPort MedBot (Group) Co stock appears to be undervalued. The current stock price of HK$25.48 is trading 68.9% below its estimated GF Value™ of HK$81.81. GuruFocus considers Shanghai MicroPort MedBot (Group) Co to be Possible Value Trap.

Key valuation signals for HKSE:02252:

  • Altman Z2-Score: -7.03
  • GF Value™: HK$81.81 vs. price of HK$25.48 (68.9% below fair value)
  • GF Score™: 45/100 with 3 warning signs

No single metric tells the full story. See the HKSE:02252 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai MicroPort MedBot (Group) Co Business Description

Address 1601 Zhangdong Road, Room 101, Area B, Building 1, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN
Shanghai MicroPort MedBot (Group) Co Ltd is a surgical robot company dedicated to designing, developing, and commercializing surgical robots to assist surgeons in performing complex surgical procedures. The business of the company covers various surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice, and percutaneous surgical procedures, and has accumulated several products at various stages as those in development, clinical trials, registration, and commercialisation. The company derives revenue principally from the sales of surgical robot systems, instruments, and accessories, and the provision of services through appointed distributors. Geographically, it derives maximum revenue from the People's Republic of China.
45GF Score

Get the complete analysis for HKSE:02252

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$25.48
Price
HK$81.81
GF Value